Franklin M. Berger - 10 Dec 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role: Director
Signature: /s/ Andrea Corcoran, as Attorney-in-Fact for Franklin M. Berger
Issuer symbol: AVIR
Transactions as of: 10 Dec 2024
Net transactions value: -$1,023,475
Form type: 4
Filing time: 12 Dec 2024, 18:00:03 UTC
Previous filing: 21 Jun 2024
Next filing: 17 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVIR	Common Stock	Sale	$1,023,475	-359,606	-44%	$2.85	451,897	10 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.955. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.955. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.